Global Anal Fissure Treatment Market Size, Trends, and Growth Opportunity, By Treatment (Nitrate Ointment, Calcium Channel Blockers, Botox Injections, Surgery, Others), By Route of Administration (Oral, Topical, Others), By Application (Intersphincteric Fistula, Transsphincteric Fistula, Suprasphincteric Fistula, Others), By End-Users (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) By Region and Forecast till 2027.
Global Anal Fissure Treatment Market
The estimated value of the global anal fissure treatment market was USD 869.32 million in 2021, and it is anticipated to grow to USD 1526.5 million by 2027 at a CAGR of 7.68%. from 2022-2027.
Anal fissure, commonly known as anal ulcer, is an anorectal condition marked by inflammation or rupture of the lower rectum's lining. It makes bowel movements extremely painful and bleed. Although not life-threatening, the illness has a significant impact on a person's quality of life. In four to six weeks, this illness usually goes away on its own. Dietary fiber, stool softeners, and topical lotions are among the usual therapies.
Market Drivers
The market is anticipated to expand at a rapid rate due to its rising older population. According to the Administration for Community Living, there will be an increase in the number of Americans 65 and older from 16% in 2019 to 21.6% by 2040. An increase in the occurrence of the sedentary lifestyle is practiced by about 28% of adults, or 1.4 billion individuals, making up almost one in four adults worldwide. The oral category is predicted to have a growing market share by the end of 2031. Oral medications include laxatives, pain relievers, calcium channel blockers, and stool softeners. Some of the topical drugs are botulinum toxin A and nitroglycerin. Because the majority of these medications are easily available over the counter, the oral therapy sector has the largest market share. Laxatives are frequently used to treat constipation in children. More than 3% of children globally suffer from functional constipation; however, 10-23% of cases are expected in North and South America. As a result, market growth accelerates.
Market Restraints
The lack of competent specialists who can provide appropriate therapies to patients may hamper market expansion throughout the projection period. The rising cost of prescription drugs is a hindrance to market expansion. Because these inhibitors are expensive, many patients in emerging and disadvantaged nations receive inadequate care. This prevents the market from growing.
Impact of COVID-19
COVID-19 has a major effect on the market for anal fistula treatments. Anal fistula treatment saw a significant delay during the COVID-19 epidemic, which put patients in an uncomfortable predicament. Based on a prior study in patients with Crohn's disease, seton placement and outpatient examination with a proctoscope were frequently the alternative options. The drugs used during COVID-19 produce symptoms of the illness in patients who have no prior history of anal fissures. According to the same publication, patients who had previously received COVID-19 treatment had a higher incidence of anal fissures. Therefore, COVID-19 has a significant effect on the market for anal fistula treatments.
Market Segmentation
Global Anal Fissure Treatment Market is segmented into Treatment, Route of Administration, Application, End-Users, and Distribution Channel. By Treatment such as Nitrate Ointment, Calcium Channel Blockers, Botox Injections, Surgery, and Others. By Route of Administration such as Oral, Topical, and Others. Applications such as Intersphincteric Fistula, Transsphincteric Fistula, Suprasphincteric Fistula, and Others. By End-User such as Hospitals, Homecare, Specialty Clinics, and Others. By Distribution Channels such as Hospital Pharmacies, Online pharmacies, and Retail pharmacies.
Regional Analysis
North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa are the five geographic segments that make up the global anal fissure treatment market. North America has experienced positive growth for the anal fissure treatment market throughout the period of forecasting due to the high prevalence of inflammatory bowel disease in the region under study, early adoption of cutting-edge technologies, and rising healthcare spending by both the public and private sectors. Due to the prevalence of generic firms and rising awareness of anorectal disorders, Asia-Pacific dominates the market.
Key Players
This report includes a list of numerous Key Players, namely RDD Pharma, Ltd (U.S.), Cipla Inc. (U.S.), Abbvie, Inc (U.S.), Novartis AG (Switzerland), Boehringer Ingelheim International GmbH. (Germany), Troikaa (India), Kyowa Kirin Co., Ltd (Japan) Teva Pharmaceutical Industries Ltd (Israel), Ipsen Pharma (France), and Sanofi (France).
Market Taxonomy
By Treatment
• · BFSI
• · Nitrate Ointment
• · Calcium Channel Blockers
• · Botox Injections
• · Surgery
• · Others
By Route of Administration
• · Oral
• · Topical
• · Others
By Application
• · Intersphincteric Fistula
• · Transsphincteric Fistula
• · Suprasphincteric Fistula
• · Others
By End User
• · Others
• · Hospitals
• · Homecare
• · Specialty Clinics
• · Others
By Distribution Channel
• · Hospital Pharmacy
• · Online Pharmacy
• · Retail Pharmacy
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Anal Fissure Treatment Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Anal Fissure Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Anal Fissure Treatment Market, By Treatment
5.1 Y-o-Y Growth Comparison, By Treatment
5.2 Global Anal Fissure Treatment Market Share Analysis, By Treatment
5.3 Global Anal Fissure Treatment Market Size and Forecast, By Treatment
5.3.1 Nitrate Ointment
5.3.2 Calcium Channel Blockers
5.3.3 Botox Injections
5.3.4 Surgery
5.3.5 Others
6 Global Anal Fissure Treatment Market, By Route of Administration
6.1 Y-o-Y Growth Comparison, By Route of Administration
6.2 Global Anal Fissure Treatment Market Share Analysis, By Route of Administration
6.3 Global Anal Fissure Treatment Market Size and Forecast, By Route of Administration
6.3.1 Oral
6.3.2 Topical
6.3.3 Others
7 Global Anal Fissure Treatment Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Anal Fissure Treatment Market Share Analysis, By Distribution Channel
7.3 Global Anal Fissure Treatment Market Size and Forecast, By Distribution Channel
7.3.1 Hospital Pharmacy
7.3.2 Online Pharmacy
7.3.3 Retail Pharmacy
8 Global Anal Fissure Treatment Market, By Application
8.1 Y-o-Y Growth Comparison, By Application
8.2 Global Anal Fissure Treatment Market Share Analysis, By Application
8.3 Global Anal Fissure Treatment Market Size and Forecast, By Application
8.3.1 Intersphincteric Fistula
8.3.2 Transsphincteric Fistula
8.3.3 Suprasphincteric Fistula
8.3.4 Others
9 Global Anal Fissure Treatment Market, By End-Users
9.1 Y-o-Y Growth Comparison, By End-Users
9.2 Global Anal Fissure Treatment Market Share Analysis, By End-Users
9.3 Global Anal Fissure Treatment Market Size and Forecast, By End-Users
9.3.1 Hospitals
9.3.2 Homecare
9.3.3 Specialty Clinics
9.3.4 Others
10 Global Anal Fissure Treatment Market, By Region
10.1 Global Anal Fissure Treatment Market Share Analysis, By Region
10.2 Global Anal Fissure Treatment Market Share Analysis, By Region
10.3 Global Anal Fissure Treatment Market Size and Forecast, By Region
11 North America Anal Fissure Treatment Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America Anal Fissure Treatment Market Share Analysis, By Treatment
11.3 North America Anal Fissure Treatment Market Size and Forecast, By Distribution Channel
11.4 North America Anal Fissure Treatment Market Size and Forecast, By Route of Administration
11.5 North America Anal Fissure Treatment Market Size and Forecast, By Application
11.6 North America Anal Fissure Treatment Market Size and Forecast, By End-Users
11.7 North America Anal Fissure Treatment Market Size and Forecast, By Country
11.7.1 U.S.
11.7.2 Canada
11.7.3 Mexico
12 Europe Anal Fissure Treatment Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe Anal Fissure Treatment Market Share Analysis, By Treatment
12.3 Europe Anal Fissure Treatment Market Size and Forecast, By Distribution Channel
12.4 Europe Anal Fissure Treatment Market Size and Forecast, By Route of Administration
12.5 Europe Anal Fissure Treatment Market Size and Forecast, By Application
12.6 Europe Anal Fissure Treatment Market Size and Forecast, By End-Users
12.7 Europe Anal Fissure Treatment Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
12.7.3 UK
12.7.4. Rest of Europe
13 Asia Pacific Anal Fissure Treatment Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific Anal Fissure Treatment Market Share Analysis, By Treatment
13.3 Asia Pacific Anal Fissure Treatment Market Size and Forecast, By Distribution Channel
13.4 Asia Pacific Anal Fissure Treatment Market Size and Forecast, By Route of Administration
13.5 Asia Pacific Anal Fissure Treatment Market Size and Forecast, By Application
13.6 Asia Pacific Anal Fissure Treatment Market Size and Forecast, By End-Users
13.7 Asia Pacific Anal Fissure Treatment Market Size and Forecast, By Country
13.7.1 China
13.7.2 Japan
13.7.3 India
13.7.4. Rest of Asia Pacific
14 Latin America Anal Fissure Treatment Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America Anal Fissure Treatment Market Share Analysis, Product Type
14.3 Latin America Anal Fissure Treatment Market Size and Forecast, By Distribution Channel
14.4 Latin America Anal Fissure Treatment Market Size and Forecast, By Route of Administration
14.5 Latin America Anal Fissure Treatment Market Size and Forecast, By Application
14.6 Latin America Anal Fissure Treatment Market Size and Forecast, By End-Users
14.7 Latin America Anal Fissure Treatment Market Size and Forecast, Country
14.7.1. Brazil
14.7.2. Rest of Latin America
15 Middle East Anal Fissure Treatment Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East Anal Fissure Treatment Market Share Analysis, By Treatment
15.3 Middle East Anal Fissure Treatment Market Size and Forecast, By Distribution Channel
15.4 Middle East Anal Fissure Treatment Market Size and Forecast, By Route of Administration
15.5 Middle East Anal Fissure Treatment Market Size and Forecast, By Application
15.6 Middle East Anal Fissure Treatment Market Size and Forecast, By End-Users
15.7 Middle East Anal Fissure Treatment Market Size and Forecast, By Country
15.7.1. Saudi Arabia
15.7.2. UAE
15.7.3. Egypt
15.7.4. Kuwait
15.7.5. South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 Abbvie, Inc
17.1.1 Overview
17.1.2 Products
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2. Novartis AG
17.2.1 Overview
17.2.2 Products
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3. Teva Pharmaceutical Industries Ltd
17.3.1 Overview
17.3.2 Products
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 Troikaa
17.4.1 Overview
17.4.2 Products
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 RDD Pharma, Ltd
17.5.1 Overview
17.5.2 Products
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Kyowa Kirin Co., Ltd
17.6.1 Overview
17.6.2 Products
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Ipsen Pharma
17.7.1 Overview
17.7.2 Products
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 Sanofi
17.8.1 Overview
17.8.2 Products
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Boehringer Ingelheim International GmbH.
17.9.1 Overview
17.9.2 Products
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Cipla Inc.
17.10.1 Overview
17.10.2 Products
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies
